SPOP-mediated nuclear ubiquitination degradation of p62/SQSTM1 contributes to HR repair Authors: Xiaojuan Yang, Ying Zhou, Qing Huang, Lingli Wang, Su Zhang, Xuyang Yang, Lei Qiu, Yang Meng, Hong Wu, Bo Zhang, Kunlin Xie, Junhong Han, Qing Zhu Published: 2026 ABSTRACT Dysregulation of Speckle-type POZ protein (SPOP) and cargo receptor p62/SQSTM1 impairs homologous recombination (HR)-mediated DNA repair by destabilizing RAD51 and FLNA, yet their mechanistic interplay in genomic stability and oncogenesis remains unclear. In this study, we found that the interaction between SPOP and p62/SQSTM1 is obviously enhanced in nucleus in response to DNA damage. Moreover, the nuclear ubiquitination of p62/SQSTM1 at lysine 7 by SPOP led to its degradation, resulting in upregulation of RAD51 and FLNA, RAD51 foci formation, and HR efficiency. In addition, patients-derived p62/SQSTM1 mutations in SPOP-binding consensus (SBC) motif (S276Y/S277G/S277I) increased radiotherapy sensitivity in vitro and in vivo, which attributes to HR deficiency caused by increased degradation of RAD51 and FLNA proteins, and decreased RAD51 and γ-H2AX foci formation. Our finding provides insight into the regulation of HR by SPOP and p62/SQSTM1, and disrupting the interaction between SPOP, p62/SQSTM1 and nuclear ubiquitination may be a potential approach for overcoming radiotherapy resistance in cancer. Introduction Genome instability and mutations are a hallmark of cancer [1], and genome integrity is partly maintained by DNA damage response (DDR) pathways [2]. DNA double-strand breaks (DSBs) are harmful lesions that can increase cell death. However, cells have multiple DDR pathways, including homologous recombination (HR) and non-homologous end-joining (NHEJ) to rapidly repair DSBs, thereby suppressing genomic instability [3]. Several different factors modulate the selection between these two repair pathways, such as cell cycle and DSB end structure [4]. NHEJ is an error-prone pathway that is activated throughout the cell cycle [5]. Whereas, HR is a homology-guided and error-free repair pathway that predominantly occurs during the S phase [5]. Therefore, HR repairs DSBs relatively more accurately than NHEJ [6]. Emerging evidence has shown that deficiency of DDR repair is positively correlated to critical gene mutations and radioresistance [7]. An E3 ubiquitin ligase substrate-binding adaptor protein, Speckle-type POZ protein (SPOP) [8], has been recognized to perform a dual role in tumorigenesis based on the cancer type. SPOP mutations have been reported in many types of cancers and recurrently in endometrial and prostate cancers [9, 10]. Interestingly, it has been indicated that SPOP induces HR rather than NHEJ [11–14]. However, how SPOP regulates genomic stability is largely unknown. Limited studies clarify the function of SPOP in cervical cancer (CC) [15–17]. First, it has shown that SPOP promotes CC metastasis and proliferation by inducing the movement of PD-1 away from PD-L1 in spatial localization [15], and also mediates paclitaxel resistance in CC cells by destabilizing the DRAK1 protein [16]. Second, SPOP fulfills pro-apoptotic function in HeLa cells [17]. Thus, SPOP is important for cell proliferation, survival, and chemoresistance. However, the effect of SPOP in CC radiation therapy remains elusive. p62/SQSTM1, a cytoplasmic protein, shuttles between the cytoplasm and nucleus. It is a well-established cargo receptor, primarily involved in various cellular processes, including oxidative stress [18]. Although the pathophysiological role of cytoplasmic p62/SQSTM1 has been extensively studied, the functions of nuclear p62/SQSTM1 and its dynamic regulation under stress conditions remain poorly understood. In 2016, Hewitt et al. reported that during DNA damage, p62/SQSTM1 interacts with nuclear RAD51 and FLNA proteins and promotes their proteasomal degradation, which impedes HR [19]. Additionally, Wang et al. found that nuclear p62/SQSTM1 sensitizes human cancers to radiation [20]. However, how p62/SQSTM1 modulates the radiotherapy sensitivity in cancer and whether p62/SQSTM1 mutations found in patients, in particularly mutations in SPOP-binding consensus (SBC) motif like S276Y/S277G/S277I, affect the sensitivity of CC cells to ionizing radiation remains unclear. In previous investigation, we observed that SPOP can regulate the radiotherapy sensitivity of lung cancer [21]. Recently, Shi et al. reported that in prostate cancer, in the absence of DNA damage, SPOP binds p62/SQSTM1 and promotes its non-degradative ubiquitination, thus suppressing Nrf2-mediated transcriptional activation [22]. Moreover, they also indicated that once SPOP and p62/SQSTM1 are co-expressed, p62/SQSTM1 specifically colocalizes with cytoplasmic SPOP rather than the nuclear SPOP [22]. However, it is unclear whether this colocalization can occur in the nucleus during DNA damage and what is the function of dynamic alteration in the interaction in cancer. In this study, we revealed that the interaction between SPOP and p62/SQSTM1 was significantly enhanced and was predominantly manifested in the nucleus in the presence of DSBs. Furthermore, nuclear SPOP ubiquitinated nuclear p62/SQSTM1 at residue K7, leading to p62/SQSTM1 nuclear ubiquitination degradation, which in turn, it upregulated the expressions of RAD51 and FLNA, key factors in HR repair. In addition, SPOP showed the effect in promotion of RAD51 foci formation and HR efficiency, contributing to radioresistance in CC. Moreover, patients-derived p62/SQSTM1 mutations in SPOP-binding consensus (SBC) motif (S276Y/S277G/S277I) decreased SPOP’s effects on the radiation sensitivity and increased the radiotherapy sensitivity of CC cells in vivo and in vitro. Mechanistically, the function of these mutations attributed to HR deficiency caused by increased degradation of RAD51 and FLNA proteins, and decreased RAD51 and γ-H2AX foci formation. Our finding provides insight into the regulation of HR by SPOP and p62/SQSTM1, and disrupting the nuclear ubiquitination between SPOP and p62/SQSTM1 may be a potential approach for overcoming radiotherapy resistance in cancer. Materials and methods Cell lines, transfection, culture, and infection HEK-293 T and CC cell lines (SiHa and HeLa) were procured from the American Type Culture Collection (ATCC). HeLa and HEK-293 T cells were propagated in DMEM, while SiHa cells were grown in MEM. DMEM and MEM were both augmented with 1% penicillin-streptomycin and 10% FBS. All the cells were maintained at 5% CO2 and 37 °C. For transient transfection, PEI (Polyethyleneimine) or Lipofectamine 3000 (Thermo) was transfected into the cells per the kit’s guide. HEK-293T cells were transfected with WT or mutant pHAGE-Flag-SPOP vehicles or pLKO-based gene-knockdown lentiviral vehicles and packing constructs. The virus-rich supernatants were harvested at 48 and 72 h post-transfection. The virus-rich serum was utilized to infect HeLa and SiHa cells in the presence of polybrene (10 μg/mL). The cells were then propagated in media augmented with 2.5 µg/mL puromycin. Supplementary Table 1 enlists the sequences of gene-specific shRNAs. Cell ionizing radiation treatment Cells were exposed to a single dose of X-ray irradiation at ambient temperature at 2 Gy and 2.08 Gy/min using the RAD SOURCE with X-RAYS. The cells were then incubated again at 37 °C and 5% CO2. Plasmids and mutagenesis HA-SPOP was cloned into the pCMV vehicle, while GST-SPOP was separately subcloned into pET28a vehicle. p62/SQSTM1 mutants S276Y, S277G, S277I, K7R, K13R, K91R, K189R, K420R, S276A, S277A, S276A/S277A (SSA), S276D, S277D, S276D/S277D (SSD), K7A, and D69A, as well as SPOP mutants, were generated by site-specific mutagenesis (Stratagene). Suxia Han at Xi’an Jiaotong University provided the pHAGE-EF-Puro-DEST, Flag-SPOP, Flag-p62/SQSTM1, p62/SQSTM1 shRNA, HA-tagged ubiquitin (HA-Ub), I-Sce I. c-myc-his-p62/SQSTM1, GFP-p62/SQSTM1, and GFP-vector were kindly provided by Ying Zhao at Peking University. SPOP shRNA plasmids were purchased from ADDGENE. Colony formation assays HeLa cells were infected with lentivirus, treated with puromycin for 2 d, and then irradiated. Briefly, the cells (1000/well) were trypsinized and propagated in a 6-well plate. For 10–14 days. When the colonies were observed, the cells were rinsed using PBS, preserved with 4% paraformaldehyde (PFA) for 20 min, dyed for 15 min with the help of crystal violet, and rinsed thrice with PBS before the stained colonies were analyzed and imaged. EdU incorporation assay For EdU analysis, the kit’s protocol was followed. Briefly, the treated cells were stained for 2 h with 50 mmol/L 5-ethynyl-20-deoxyuridine at 37 °C. For the Hoechst-positive cells assessment, the cells were preserved in 4% PFA, permeabilized with 0.5% Triton X-100, stained for 30 min using 1× Click Reaction Solution, and then counterstained with Hoechst 33342 for another 30 min. The Hoechst- and EdU-positive cells were immediately analyzed under an inverted fluorescence microscope (OLYMPUS IX81). RNA isolation and quantitative real-time PCR The stable transfected cell’s total RNA was isolated using the Cell Total RNA Isolation Kit (FOREGENE) and reverse transcribed for cDNA synthesis by following the instructions provided in the PrimeScript RT Master Mix Kit (Vazyme). For PCR amplification, the AceQ Universal SYBR qPCR Master Mix Kit (Vazyme) was employed, and the data were normalized against that of internal control GAPDH. Supplementary Table 1 depicts the sequences of primers utilized for the SYBR qPCR. Immunoblotting Cells (2 × 105/well) were propagated in 6-well plates for optimized time, treated, collected, and then digestion in Nuclear Lysis buffer augmented with a 1% protease inhibitor cocktail for total protein extraction. The acquired proteins were then subjected to SDS-PAGE separation, transferred to a PVDF membrane, blocked for 60 min using 5% skimmed milk, and then probed overnight with suitable primary antibody at 4 °C. The next day, the membranes were treated for 120 min with secondary antibody at ambient temperature. For immunoreactive bands detection, an enhanced chemiluminescence reagent was employed. GAPDH was set as the endogenous reference. Supplementary Table 1 indicates the antibodies used for this analysis. Immunoprecipitation (IP) assay Briefly, cells were rinsed with PBS, harvested via enzyme disaggregation and centrifugation, and resuspended with protease inhibitors containing IP lysis buffer [glycerol (5%), NP-40 (1%), NaCl (137 mM), Tris (20 mM), and MEDTA (2 mM); pH 7.5] for 30 min at 4 °C. The acquired solution was subjected to 2 h or overnight of IP utilizing anti-tag antibody-coated magnetic beads or antibodies against target genes at 4 °C with constant rotation. The beads were rinsed with washing buffer thrice for 5 min each time, and the beads bound proteins were collected in loading buffer and assessed via Western blotting. Chromosome/nuclear/cytoplasmic fractionation Cells (3 × 106) were rinsed with PBS twice, resuspended in 200 μL of buffer A [HEPES (pH 7.9; 10 mM), Triton X-100 (0.1%), KCl (10 mM), sucrose (0.34 M), glycerol (10%), MgCl2 (1.5 mM), dithiothreitol (1 mM), and protease inhibitor mixture (Roche Molecular Biochemicals)], and incubated on ice for 5 min. Using the low-speed centrifuge (1500 × g, 4 min, 4 °C), nuclei were collected in the pellet (P1). The insoluble aggregates and cell debris were removed from the supernatant (S1) by a high-speed centrifuge (10 min, 13,000 × g, 4 °C) and the acquired supernatant was labeled S2. Nuclei were rinsed with buffer A lacking Triton X-100 and then lysed with 200 μL of buffer B [dithiothreitol (1 mM), EGTA (0.2 mM), EDTA (3 mM), and protease inhibitor mixture) for 10 min on ice. Then, chromatin was separated from the soluble nuclear proteins (S3) by 4 min of centrifugation (2000 × g). The isolated chromatin (P3) was rinsed with buffer B and centrifuged for 1 min at high speed (13,000 × g) to acquire the pellet (P3), which was then re-dissolved in sample buffer and stored at −20 °C until use. Subcellular fractionation The nuclear and cytoplasmic fractions were acquired using the NE-PER™ Nuclear and Cytoplasmic Extraction Reagents (Thermo Fisher Scientific), per the kit’s guide. In vivo ubiquitination assay For this analysis, the denaturing IP protocol was followed. Briefly, the cells were washed using PBS and centrifuged to acquire a pellet, which was then subjected to subcellular fractionation as aforementioned. For IP, a GFP antibody was employed. Lastly, polyubiquitylated protein bands were visualized by Western blot analysis. Immunofluorescence Cells (2 × 104/well) were propagated on glass coverslips in 24-well plates, treated, preserved for 2 h with 4% formaldehyde, permeabilized for 20 min via 0.5% Triton X-100, and occluded for 30 min with 3% BSA. The cells were then probed with primary antibodies (1:200) and Alexa Fluor secondary antibodies. DAPI (1:1000) was employed to stain the nuclei for 15 min, and cells were analyzed under the confocal laser scanning microscope (Zeiss, LSM 880). Protein complexes purification and GST pull-down assays GST-SPOP was transformed into DE3 (BL21). The GST-SPOP expression was induced by IPTG (0.5 mM) for 16 h at 16 °C. DE3 was dissolved in 50 mL of PBS buffer [NaCl (140 mM), KCl2 (2.7 mM), Na2HPO4 (10 mM), KH2PO4 (1.8 mM), PMSF (1 mM); pH 7.5], sonicated and centrifuged for 20 min at 4 °C and 12,000 × g. All supernatant was added to a gravity column, and then 15 mL of elution buffer (10 mM reduced glutathione and 50 mM Tris-HCl) was utilized. The target protein levels in supernatants were assessed by SDS-PAGE and Coomassie blue staining. c-myc-his-p62/SQSTM1 was transformed into DE3 (BL21). The IPTG (0.5 mM) was employed to induce the expression of these proteins at 16 °C for 16 h, and DE3 was suspended in 50 mL of lysis buffer [NaCl (0.5 M), glycerin (5%), imidazole (10 mM), NP-40 (1%), Tween 20 (0.25%), Tris-HCl (0.5 mM), PMSF (1 mM) pH 8], sonicated and centrifuged for 12,000 × g at 4 °C for 20 min. All supernatant was added to a gravity column, and then 15 mL of elution buffer (50 mM Tris-HCl, 0.5 M NaCl, 50 mM imidazole, 5% glycerin, 0.05% Tween 20, pH 8.0) and an enrichment column were used to concentrate the protein white to 1 mL. The target protein levels in supernatants were assessed by SDS-PAGE and Coomassie blue staining. The GST and His proteins were incubated in GST binding buffer [(Tris-HCl (25 mM), EDTA (1 mM), NaCl (200 mM), imidazole (30 mM), NP-40 (0.01%); pH 7.5] at 4 °C overnight. On the second day, 30 μL of GST beads were added to the reaction system for 2 h at 4 °C. The beads were then rinsed thrice with 1 mL of GST binding buffer for 5 min each time. The protein interactions were assessed by SDS-PAGE and Western blotting staining. Vitro ubiquitination assay The experimental procedure was performed according to the Enzo Ubiquitinylation Kit (Catalog #: BML-UW9920) with the following protocol: Purified proteins, including the scaffold part of Cullin-3 E3 ubiquitin ligase (His-Cul3-Rbx1), GST-SPOP, His-p62-WT, His-p62-K7R, and His-p62-K420R, were prepared. On ice, the following components were combined: 100 nM E1, 2 μM GST-UBch5b, 100 nM His-Cul3-Rbx1, 100 nM GST-SPOP, 1 μM His-p62-WT or His-p62-K7R/K420R, 2.5 μM Ub, 15 mM Mg-ATP, 10 μL inorganic pyrophosphatase solution (IPP, 100 U/mL), 1 μL DTT (50 mM), 5 μL 10× ubiquitin buffer, and deionized water was added to a final reaction volume of 50 μL. The mixture was gently mixed and incubated at 37°C for 5 hours. HR repair assay After I-Sce I induced DNA DBS, site-specific recombination was assessed as mentioned previously [23, 24]. Briefly, empty or I-Sce I–expressing vector was transfected into the DR-U2OS cells for 72 h. Then, using enzyme disaggregation, cells were collected and re-suspended in 10% FBS augmented PBS buffer. GFP-positive cells were sorted via FACSort flow cytometer at 10,000 events per sample, and the data were analyzed by FlowJo software. NHEJ assay After I-Sce I induced DNA DBS, site-specific recombination was assessed as mentioned previously [24]. EJ5-GFP cells were transfected for 72 h with either an I-Sce I–expressing plasmid or an empty control vector. After enzymatic dissociation, cells were collected and resuspended in PBS containing 10% fetal bovine serum. GFP-positive cells were then sorted on a FACSort flow cytometer, with 10,000 events acquired per sample. Data were analyzed using FlowJo. Comet assay The comet assay was conducted according to the protocol previously published by our group [24]. Briefly, cells were washed three times with PBS, mixed with low-melting agarose, and then lysed. The samples were pipetted onto slides pre-coated with low-melting agarose and immersed in alkaline lysis buffer at 4 °C overnight in the dark. Following lysis, electrophoresis was conducted at 0.6 V/cm for 25 min, and the slides were stained with EB for 10 min. Images of randomly selected cells were captured using an LSM880 Zeiss laser confocal microscope. DNA tail length was measured using ImageJ software (NIH), with the relative length and intensity of the DNA tail compared to the head serving as an indicator of DNA damage in individual nuclei. Xenograft experiments All animal protocols were authorized by the Institutional Animal Care and Treatment Committee of Sichuan University (Chengdu, China) and followed the NIH Guide for the Care and Use of Laboratory Animals. The sample sizes were calculated via Lamorte’s power calculation tool (spreadsheet), in line with our earlier publication [25]. NOD (NOD/ShiltJGpt-Prkdcem26Cd52Il2rgem26Cd22/Gpt) (GemPharmatech Co., Ltd) mice (female, age = 6 weeks, n = 5 per group) were utilized for establishing the Xenograft models. HeLa cells (1 × 107 cells/mouse) transfected with empty, p62/SQSTM1-WT, and mutant vehicles were injected subcutaneously into the right flanks of the mice. Mice in the irradiation group were irradiated by a RAD SOURCE via X-RAYS at a dose rate of 1.22 Gy/min, 160 kV, and 25 mA. Caliper measurements were employed to assess tumor growth, while tumor volumes were evaluated using the formula volume = (width2 × length)/2 [26]. Finally, tumors were dissected for Western blot analysis or embedded in paraffin for histochemical assessment. Immunohistochemistry The dissected tumor samples were submerged in paraffin, sliced (4 mm thick), dewaxed, and rehydrated, and their endogenous peroxidase activity was quenched. Section’s antigen was then retrieved using citrate buffer, and they were probed overnight with primary antibodies at 4 °C, followed by staining with diaminobenzidine and counterstaining with Mayer hematoxylin. Lastly, after H&E staining, the sections were imaged via a DM2500 fluorescence microscope. Statistical analysis For all statistical measurements, GraphPad Prism v8.0.1 (La Jolla, CA, USA; https://www.graphpad.com) was employed. Statistical significance was evaluated via one/two-way ANOVA or Student’s t-test. All data are depicted as the mean ± standard deviation (SD). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 were deemed statistically significant. Results DSBs enhances the interaction between p62/SQSTM1 and SPOP Our previous results revealed positively correlation between SPOP and DDR [21]. However, proteins involved in DDR and also binding to SPOP are still unknown. Since p62/SQSTM1 is reported to mediate DDR [19, 20] and can interact with SPOP via the SPOP-binding consensus (SBC) motif [22], we found that only one region in p62/SQSTM1 contains a conserved SBC motif in various species (Fig. S1A, B). Moreover, the interaction between SPOP and p62/SQSTM1 was verified by co-immunoprecipitation (co-IP) (Fig. S1C, D). To further confirm the interaction, we performed in vitro GST pull-down assay using purified recombinant proteins (Fig. S1E), and the results supported that SPOP indeed binds to p62/SQSTM1 (Fig. 1A). Although it was previously found that SPOP can interact with p62/SQSTM1, the cytoplasmic SPOP interacted with and induced non-degradative ubiquitination of p62/SQSTM1. Moreover, in the absence of DSBs, p62/SQSTM1 was exclusively colocalized with cytoplasmic SPOP but not with nuclear SPOP.Fig. 1SPOP binds p62/SQSTM1, and IR enhances this interaction.A SPOP binds to p62/SQSTM1 in vitro. Glutathione-Sepharose beads loaded with recombinant GST-SPOP (10 μg) were incubated with p62/SQSTM1-His protein. After extensive washing with bead binding buffer, bound proteins were eluted using 1× RIPA buffer, separated by SDS-PAGE, and analyzed by Western blot using the indicated antibodies. GST (10 μg) was used as a negative control in all experiments. B Induction of DSBs by the indicated treatments—IR and Etop—as evidenced by γ-H2AX foci formation detected by immunofluorescence. Scar bar: 100 μm. C, D Co-immunoprecipitation of endogenous SPOP and p62/SQSTM1 from HeLa cell lysates without IR or following 2 Gy IR for 5 h, followed by mass spectrometry analysis. E Co-immunoprecipitation of endogenous SPOP and p62/SQSTM1 from HeLa cell lysates without IR or following 2 Gy IR for 5 h. Immunoprecipitation was performed using an anti-SPOP antibody, and immunoblots were probed with the indicated antibodies. Co-immunoprecipitation of endogenous SPOP and p62/SQSTM1 from nuclear proteins of HeLa (F) and SiHa (G) cells without IR or following 2 Gy IR for 5 hours. HeLa (H) and SiHa (I) cells were irradiated with 2 Gy or treated with 1 µM Etop, and then stained for 5 h after irradiation or 2 h after Etop exposure. Scar bar: 5 μm. Abbreviations: DSBs DNA double-strand breaks, Etop Etoposide, IR irradiation. SPOP binds p62/SQSTM1, and IR enhances this interaction. A SPOP binds to p62/SQSTM1 in vitro. Glutathione-Sepharose beads loaded with recombinant GST-SPOP (10 μg) were incubated with p62/SQSTM1-His protein. After extensive washing with bead binding buffer, bound proteins were eluted using 1× RIPA buffer, separated by SDS-PAGE, and analyzed by Western blot using the indicated antibodies. GST (10 μg) was used as a negative control in all experiments. B Induction of DSBs by the indicated treatments—IR and Etop—as evidenced by γ-H2AX foci formation detected by immunofluorescence. Scar bar: 100 μm. C, D Co-immunoprecipitation of endogenous SPOP and p62/SQSTM1 from HeLa cell lysates without IR or following 2 Gy IR for 5 h, followed by mass spectrometry analysis. E Co-immunoprecipitation of endogenous SPOP and p62/SQSTM1 from HeLa cell lysates without IR or following 2 Gy IR for 5 h. Immunoprecipitation was performed using an anti-SPOP antibody, and immunoblots were probed with the indicated antibodies. Co-immunoprecipitation of endogenous SPOP and p62/SQSTM1 from nuclear proteins of HeLa (F) and SiHa (G) cells without IR or following 2 Gy IR for 5 hours. HeLa (H) and SiHa (I) cells were irradiated with 2 Gy or treated with 1 µM Etop, and then stained for 5 h after irradiation or 2 h after Etop exposure. Scar bar: 5 μm. Abbreviations: DSBs DNA double-strand breaks, Etop Etoposide, IR irradiation. We also examined whether DSBs alter the interaction between SPOP and p62/SQSTM1. First, we observed that both ionizing radiation (IR) and a topoisomerase II inhibitor Etoposide (Etop) markedly increased γ-H2AX foci relative to controls, indicating robust induction of DSBs (Fig. 1B). We then performed immunoprecipitation coupled with quantitative proteomics to compare the SPOP interactome in irradiated versus non-irradiated cells. Our findings revealed that p62 was present in both groups, with a higher level of p62 enrichment observed following irradiation (Fig. 1C, D and Supplementary Material 1 and 2). Subsequently, our experimental assays revealed a significant increase in the interaction in response to DNA damage in both HeLa and SiHa cells (Figs. 1E and S1F). Previous findings indicate that SPOP-p62/SQSTM1 interaction in cytoplasm induces non-degradative ubiquitination of p62/SQSTM1, and p62/SQSTM1 is exclusively colocalized with cytoplasmic SPOP but not with nuclear SPOP in cells without DSBs [22]. Thus, we were wondering whether DSBs is able to alter the interaction in nucleus. As expected, the interaction was significantly enhanced in the nucleus, as evidenced by both quantitative proteomics analysis and nuclear-cytoplasmic fractionation IP experiments (Supplementary Materials 1–2 and Fig. 1F, G). In addition, cells treated with IR or Etop showed substaintial increase in colocalization of SPOP-p62/SQSTM1 in the nucleus (Figs. 1H, I and S1G, H). Together, these data clearly indicates that DSBs can enhance the interaction between SPOP and p62/SQSTM1 in the nucleus. SPOP negatively regulates p62/SQSTM1 expression and particularly its distribution in nucleus To further define SPOP’s role in the DDR, we first tested whether altering SPOP abundance affects p62/SQSTM1 under steady-state conditions. Consistent with previous reports [22], neither SPOP overexpression nor knockdown changed p62 protein levels (Fig. 2A). We then asked whether SPOP overexpression or depletion alters p62/SQSTM1 levels after DSB induction by Etop or IR. To this end, SPOP stable overexpression or knockdown HeLa and SiHa cell lines were established, and we found significantly increased expression of p62/SQSTM1 in cells after SPOP knockdown, while SPOP overexpression obviously reduced p62/SQSTM1 expression in the presence of Etop (Fig. 2B, C).Fig. 2SPOP promotes proteasomal degradation of nuclear p62/SQSTM1 upon DSBs.A HeLa cells were transfected with either control (empty vector) or SPOP‑targeting shRNA together with either empty vector or Flag–SPOP, treated with DMSO for 2 h, and analysed by Western blot with the indicated antibodies. B HeLa and SiHa cells were transfected with shRNA targeting SPOP, exposed to Etop for 2 h, and analyzed by Western blot using the indicated antibodies. C SiHa and HeLa cells were transfected with either an empty vector or Flag-SPOP, exposed to Etop for 2 h, and assessed by Western blot using the indicated antibodies. D Cellular fractions from HEK-293T were extracted and analyzed to determine p62/SQSTM1 protein levels in the nucleus, chromatin, and cytoplasm. E Upon overexpression of SPOP, cell fractions extracted from treated HeLa cells were analyzed to evaluate the distribution of SPOP and p62/SQSTM1 protein across the nucleus, chromatin, and cytoplasm. F HeLa cells were transfected with Flag-SPOP or empty vector, irradiated, and subjected to cellular fractionation at the indicated time points. Chromatin and cytoplasmic fractions were analysed for p62/SQSTM1 and SPOP, with GAPDH and histone H3 serving as loading controls. G HeLa cells were transfected with Flag–SPOP or empty vector and pre‑incubated with MG132 for 8 h. Cells were then treated with Etop in the continued presence of MG132 for an additional 2 h. Chromatin fractions were analysed for p62/SQSTM1 and SPOP, with histone H3 as a loading control. H Western blots of the indicated proteins and relative quantification of p62/SQSTM1 protein levels in HeLa cells. I Quantification of p62/SQSTM1 levels in thechromatin and cytoplasm, as well as in whole-cell lysates (WCL) from CHX (150 μg/mL)-treated HeLa cells at the indicated times. Protein band quantification was performed using ImageJ software. Student’s t-test. Abbreviations: DSBs DNA double-strand breaks, Etop Etoposide, IR irradiation, min minutes. SPOP promotes proteasomal degradation of nuclear p62/SQSTM1 upon DSBs. A HeLa cells were transfected with either control (empty vector) or SPOP‑targeting shRNA together with either empty vector or Flag–SPOP, treated with DMSO for 2 h, and analysed by Western blot with the indicated antibodies. B HeLa and SiHa cells were transfected with shRNA targeting SPOP, exposed to Etop for 2 h, and analyzed by Western blot using the indicated antibodies. C SiHa and HeLa cells were transfected with either an empty vector or Flag-SPOP, exposed to Etop for 2 h, and assessed by Western blot using the indicated antibodies. D Cellular fractions from HEK-293T were extracted and analyzed to determine p62/SQSTM1 protein levels in the nucleus, chromatin, and cytoplasm. E Upon overexpression of SPOP, cell fractions extracted from treated HeLa cells were analyzed to evaluate the distribution of SPOP and p62/SQSTM1 protein across the nucleus, chromatin, and cytoplasm. F HeLa cells were transfected with Flag-SPOP or empty vector, irradiated, and subjected to cellular fractionation at the indicated time points. Chromatin and cytoplasmic fractions were analysed for p62/SQSTM1 and SPOP, with GAPDH and histone H3 serving as loading controls. G HeLa cells were transfected with Flag–SPOP or empty vector and pre‑incubated with MG132 for 8 h. Cells were then treated with Etop in the continued presence of MG132 for an additional 2 h. Chromatin fractions were analysed for p62/SQSTM1 and SPOP, with histone H3 as a loading control. H Western blots of the indicated proteins and relative quantification of p62/SQSTM1 protein levels in HeLa cells. I Quantification of p62/SQSTM1 levels in thechromatin and cytoplasm, as well as in whole-cell lysates (WCL) from CHX (150 μg/mL)-treated HeLa cells at the indicated times. Protein band quantification was performed using ImageJ software. Student’s t-test. Abbreviations: DSBs DNA double-strand breaks, Etop Etoposide, IR irradiation, min minutes. To rule out a possibility that the dynamic change in p62/SQSTM1 protein levels is casuesd by transcription, we examined p62/SQSTM1 mRNA level by qRT-PCR. The results showed that there was a subtle variation in cells with either SPOP overexpression or knockdown (Fig. S2A–D), suggesting the change of p62/SQSTM1 protein possiblely occur at post-translational layer. We have shown that SPOP negatively regulate p62/SQSTM1 expression during DSBs, therefore, we sought to figure out the underlying mechanisms by which SPOP regulates p62/SQSTM1 expression. Using celluar fractionation assay, we found that SPOP is mainly distributed in nucleus and is associated with chromatin, while the majority of p62/SQSTM1 is in cytoplasm (Fig. 2D). Furthermore, upon DNA damage induced by Etop, under SPOP overexpression, the disctribution of p62/SQSTM1 was decreased in nucleus but not in cytoplasm (Figs. 2E and S2E), and γ-H2AX foci was remarkable reduction in HeLa and SiHa cells with stable SPOP expression as well (Fig. S2F–I). Similar with Etop treatment, cells exposed to IR also showed obvious reduction of p62/SQSTM1 after SPOP overexpression (Fig. 2F). Together, these results indicate a critical role of SPOP in regulation of p62/SQSTM1 expression during DDR. To investigate how SPOP protein reduces the distribution of p62/SQSTM1 in nucleus, we detected p62/SQSTM1 expression in HeLa cells with stable SPOP overexpression in the presence of MG132, a proteasomal degradation inhibitor. The results indicated that MG132 treatment successfully block the reduction of p62/SQSTM1 in nucleus caused by SPOP overexpression during DSBs, implying that p62/SQSTM1 stability was modulated via the proteasomal degradation pathway (Fig. 2G). To further validate this hypothesis, we examined p62/SQSTM1 distribution in different fractionation in HeLa cells after blocking protein synthesis by cycloheximide (CHX). It clearly showed that both total p62/SQSTM1 and its distribution in nucleus are obvious decreased 8 h after CHX treatment, however, its distribution in cytoplasm is even increased after treatment and only has minor reduction at 12 hour point, which is partially consistent with a previous report [27] (Fig. 2H, I). This result supports the hypothesis about nuclear p62/SQSTM1 stability negatively regulated by SPOP via proteasomal degradation under DSBs conditions. SPOP-mediated nuclear ubiquitination of p62/SQSTM1 at the K7 site in response to IR This research validated that SPOP degrades nuclear p62/SQSTM1 by proteasomal degradation pathway after DNA DSBs. A previous study indicates that cytoplasmic SPOP can interact with p62/SQSTM1 and promote its non-degradative ubiquitination at residue K420 in the absence of DSBs [22]. Our data suggest that p62/SQSTM1 stability negatively regulated by SPOP via nuclear ubiquitination proteasomal degradation. Thus, we can reasonably infer that SPOP likely mediates the nuclear ubiquitination of p62/SQSTM1, targeting it for degradation in the presence of DSBs. Prior work identified p62 lysines K7, K13, K91, K189, and K420 as substrates of the E3 ligases TRIM21, Parkin, RNF166, Keap1, and cytoplasmic SPOP [22]. Next, using AlphaFold3-derived models, we mapped the SPOP–p62 interaction interface and annotated the putative p62/SQSTM1 ubiquitination sites (K7, K13, K91, K189, and K420) (Fig. 3A–D). And we also found that 12 pairs of hydrogen bonds and 9 pairs of salt bridges are required for SPOP-p62/SQSTM1 interaction required (Supplementary Table 2). To validate these potential ubiquitynation sites, we constructed single K → R point mutation in p62/SQSTM1 and detected its ubiquitynation in cells treated with IR. Subcellular fractionation and in vivo ubiquitination assays were conducted to evaluate whether SPOP ubiquitinates cytoplasmic and nuclear p62/SQSTM1 through these lysine residues when exposed to IR. It was observed that only p62/SQSTM1-K420R mutant was less ubiquitinated by SPOP in the cytoplasm, consistent with previous research [22] (Fig. 3E). In addition, only the p62/SQSTM1-K7R mutant was less ubiquitinated by SPOP in the nucleus, suggesting that K7 is a critical and functionally validated nuclear ubiquitination site (Fig. 3E). Altogether, the data indicated that in the case of DNA DSB, SPOP induces degradative nuclear ubiquitination of p62/SQSTM1, and K7 of p62/SQSTM1 is a critical nuclear ubiquitin attachment site. Building on the initial purification of GST-SPOP and His-p62 (Fig. S1E), we subsequently purified the Cullin3-RBX1 fusion protein, His-p62-K7R, and His-p62-K420R for in vitro ubiquitination assays (Fig. S3A–C). These experiments further confirmed the results (Fig. 3F).Fig. 3SPOP ubiquitylates K7 of nuclear p62/SQSTM1 in response to IR.A Structure of SPOP predicted by AlphaFold3. B Structure of p62/SQSTM1 predicted by AlphaFold3. C Predicted interaction between SPOP and p62/SQSTM1 based on AlphaFold3 modeling. D p62/SQSTM1 ubiquitination sites (K7, K13, K91, K189, K420) displayed on the AlphaFold3 model. E HEK-293T cells were transfected with the indicated plasmids, treated with 10 μM MG132 for 8 h, exposed to 2 Gy IR, and harvested 5 hours later, followed by nuclear-cytoplasmic fractionation. A vivo ubiquitination assay was performed, followed by Western blot analysis using the indicated antibodies. F In the vitro ubiquitination assay, polyubiquitination was detected using an anti-ubiquitin antibody. Abbreviations: IR irradiation. SPOP ubiquitylates K7 of nuclear p62/SQSTM1 in response to IR. A Structure of SPOP predicted by AlphaFold3. B Structure of p62/SQSTM1 predicted by AlphaFold3. C Predicted interaction between SPOP and p62/SQSTM1 based on AlphaFold3 modeling. D p62/SQSTM1 ubiquitination sites (K7, K13, K91, K189, K420) displayed on the AlphaFold3 model. E HEK-293T cells were transfected with the indicated plasmids, treated with 10 μM MG132 for 8 h, exposed to 2 Gy IR, and harvested 5 hours later, followed by nuclear-cytoplasmic fractionation. A vivo ubiquitination assay was performed, followed by Western blot analysis using the indicated antibodies. F In the vitro ubiquitination assay, polyubiquitination was detected using an anti-ubiquitin antibody. Abbreviations: IR irradiation. SPOP regulates RAD51 and γ-H2AX foci formation and homologous recombination efficiency in a p62/SQSTM1-dependent manner during DNA DSBs To determine how SPOP-dependent degradation of nuclear p62 affects the DDR, we measured HR repair and NHEJ repair efficiencies after Etop or IR; both treatments significantly increased HR repair efficiencies and NHEJ repair efficiencies (Fig. S4A). Because SPOP and p62 primarily regulate HR repair rather than NHEJ repair [28, 29], we next defined the mechanism by which the SPOP–p62 axis controls HR repair. Given that p62/SQSTM1 interacts with nuclear RAD51 and FLNA—both key factors in HR repair—and promotes their proteasomal degradation by acting as a ubiquitinated protein cargo receptor, facilitating the proteasomal turnover of RAD51 and FLNA [19], we want to know whether SPOP and p62/SQSTM1 modulate RAD51–γ-H2AX colocalization. Under basal conditions (no Etop or IR), RAD51 foci and γ-H2AX signals were negligible, and colocalization was not evident (Fig. S4B–E). Interestingly, when DNA DSBs occur, we did not observe colocalization between FLNA and γ-H2AX, nor any change in γ-H2AX foci formation in cells (Fig. S4F). In HeLa cells, SPOP deficiency markedly reduced RAD51–γ-H2AX colocalization (Fig. 4A, B and S4G-H), whereas SPOP overexpression increased colocalization after DSB induction by either Etop or IR (Figs. 4C, D and S4I–J). Moreover, we also observed that p62/SQSTM1 has an opposite effect on the colocalization of RAD51 and γ-H2AX compared to SPOP when DNA DSBs occur (Fig. S5A–H), and knockdown of p62/SQSTM1 partially restored RAD51–γ-H2AX colocalization in SPOP-deficient cells following DSB induction by either Etop or IR(Figs. 4E, F and S5I–J). This rationale is further supported by the result from co-overexpression of SPOP and p62/SQSTM1 in HeLa cells (Fig. 4G, H and S5K, L) and additional evidence from SiHa cells (Fig. S6A–H) when DNA DSBs occur. These data suggest that SPOP can enhance RAD51 and γ-H2AX colocalization formation in a p62/SQSTM1-dependent manner. Meanwhile, our results revealed that SPOP knockdown impaired HR repair efficiency, while p62 knockdown enhanced it, consistent with previous findings [12, 19, 20] (Fig. S7A–F). Importantly, p62 knockdown partially rescued impaired HR repair caused by SPOP knockdown by both Etop and IR (Fig. 4I, J). Together, the results above indicate a critical role of SPOP-p62/SQSTM1 axis in HR repair.Fig. 4SPOP regulates nuclear RAD51 and γ-H2AX foci and HR efficiency via p62/SQSTM1.A–D Representative immunofluorescence images of nuclear RAD51 and γ-H2AX foci in HeLa cells after SPOP knockdown or overexpression, following treatment with etoposide (Etop, 1 µM, 2 h) or ionizing radiation (IR, 2 Gy, 5 h recovery). Scale bar = 10 μm. Images show enlargements of selected fields. E–H Immunostaining of HeLa cells transfected with the indicated plasmids and subjected to Etop or IR treatment. Scale bar = 10 μm. Images are enlargements of selected fields. I, J HR efficiency assay measuring I-Sce I endonuclease-induced chromosomal DSBs and total GFP-positive cells in DR-GFP U2OS cells. *p < 0.05, **p < 0.01, Student’s t-test. Abbreviations: Etop etoposide, HR Homologous recombination; IR irradiation. SPOP regulates nuclear RAD51 and γ-H2AX foci and HR efficiency via p62/SQSTM1. A–D Representative immunofluorescence images of nuclear RAD51 and γ-H2AX foci in HeLa cells after SPOP knockdown or overexpression, following treatment with etoposide (Etop, 1 µM, 2 h) or ionizing radiation (IR, 2 Gy, 5 h recovery). Scale bar = 10 μm. Images show enlargements of selected fields. E–H Immunostaining of HeLa cells transfected with the indicated plasmids and subjected to Etop or IR treatment. Scale bar = 10 μm. Images are enlargements of selected fields. I, J HR efficiency assay measuring I-Sce I endonuclease-induced chromosomal DSBs and total GFP-positive cells in DR-GFP U2OS cells. *p < 0.05, **p < 0.01, Student’s t-test. Abbreviations: Etop etoposide, HR Homologous recombination; IR irradiation. SPOP-p62/SQSTM1 axis maintains the stability of RAD51 and FLNA proteins On the basis of these data, DSBs induced by Etop or IR produced comparable effects on SPOP–p62–regulated HR repair processes—RAD51–γ-H2AX colocalization and HR repair efficiency. We therefore prioritized Etop for subsequent mechanistic studies and used IR as a complementary modality. It has shown that SPOP can control RAD51 protein expression [14, 21, 30], however, the conclusion is not solid enough even remains controversial. Thus, we validated the expression of RAD51 and FLNA in SPOP deficient cells. Indeed, lack of SPOP in cells resulted in expression reduction of RAD51 and FLNA under DNA damage induced by Etop (Fig. 5A), while ectopic expression of SPOP had the opposite effect (Fig. 5B). Considering the critical role of SPOP-p62/SQSTM1 axis in HR repair, and there is a clue showing regulation on protein levels of RAD51 and FLNA by p62/SQSTM1 in the proteasomal pathway [19], we thought to verify whether p62/SQSTM1 negatively controls the expression of key components in HR repair machinery. Indeed, we observed the reduction of RAD51 and FLNA caused by p62/SQSTM1 overexpression, which is also supported by the results from p62/SQSTM1 knockdown (Fig. 5C). To rule out the possibility that the reduction of RAD51 and FLNA is caused by defective transcription, we detected their mRNA levels in cells lacking SPOP, lacking p62, overexpressing SPOP, or overexpressing p62. However, neither RAD51 nor FLNA mRNA levels were altered under any of these conditions (Figs. 5D–G and S7G, H), suggesting expression reduction of RAD51 and FLNA is possibly caused by posttranslational pathway rather than defective transcription. As we expected, the increase of RAD51 and FLNA protein by SPOP overexpression under DNA damage caused by Etop was blocked by complementary p62/SQSTM1 (Fig. 5H), suggesting p62/SQSTM1 is critical for maintaining the stability of RAD51 and FLNA.Fig. 5SPOP regulates the protein levels of RAD51 and FLNA via p62/SQSTM1 in a transcription-independent manner.A Western blot analysis of WCL from HeLa or SiHa cells transduced with lentiviruses encoding shRNAs targeting SPOP (shSPOP), with Scramble as the negative control. B Western blot assessment of WCL from HeLa or SiHa cells stably expressing Flag-SPOP or an empty vector. C Western blotting of WCL from HeLa cells transduced with lentiviruses encoding shRNAs targeting p62 (shp62), with Scramble as the negative control, or stably expressing Flag-p62 or an empty vector. D, E HeLa cells infected with lentivirus expressing shSPOP or scramble, or transfected with Flag-SPOP or empty vector, were subjected to total cellular RNA extraction for RT-qPCR analysis after exposure to Etop for 2 h. Data are presented as mean ± SD from three independent experiments. **p < 0.01, ***p < 0.001, ****p < 0.0001, ns = not significant (Student’s t-test). F, G HeLa cells infected with the corresponding plasmids were subjected to total cellular RNA extraction for RT-qPCR analysis after exposure to etoposide for 2 h. Data are presented as mean ± SD from three independent experiments. ***p < 0.001, ns = not significant (Student’s t-test). H Western blot of HeLa cells infected with lentivirus expressing the indicated plasmids. Abbreviations: Etop Etoposide, WCL whole-cell lysates. SPOP regulates the protein levels of RAD51 and FLNA via p62/SQSTM1 in a transcription-independent manner. A Western blot analysis of WCL from HeLa or SiHa cells transduced with lentiviruses encoding shRNAs targeting SPOP (shSPOP), with Scramble as the negative control. B Western blot assessment of WCL from HeLa or SiHa cells stably expressing Flag-SPOP or an empty vector. C Western blotting of WCL from HeLa cells transduced with lentiviruses encoding shRNAs targeting p62 (shp62), with Scramble as the negative control, or stably expressing Flag-p62 or an empty vector. D, E HeLa cells infected with lentivirus expressing shSPOP or scramble, or transfected with Flag-SPOP or empty vector, were subjected to total cellular RNA extraction for RT-qPCR analysis after exposure to Etop for 2 h. Data are presented as mean ± SD from three independent experiments. **p < 0.01, ***p < 0.001, ****p < 0.0001, ns = not significant (Student’s t-test). F, G HeLa cells infected with the corresponding plasmids were subjected to total cellular RNA extraction for RT-qPCR analysis after exposure to etoposide for 2 h. Data are presented as mean ± SD from three independent experiments. ***p < 0.001, ns = not significant (Student’s t-test). H Western blot of HeLa cells infected with lentivirus expressing the indicated plasmids. Abbreviations: Etop Etoposide, WCL whole-cell lysates. SPOP-p62/SQSTM1 axis regulates radioation response Given that SPOP-p62/SQSTM1 contribution in modulating foci formation of RAD51 and γ-H2AX, it is reasonable to agure its role in regulation on radiation response in cancer. To assess whether loss of SPOP could increase radiation response by attenuating DNA repair, we performed colony formation assay and observed notable reduction in colony numbers in IR treated cells with SPOP deficiency (Fig. 6A, B). This increased sensitivity to radioation was due to impaired DNA repair, but not DNA replication deficiency, in SPOP deficient cells (Fig. 6C–E).Fig. 6SPOP regulates the radiation sensitivity of cervical cancer through p62/SQSTM1 in a DNA damage repair-dependent, proliferation-independent manner.A, B Colony formation assay of SiHa cells infected with lentivirus expressing SPOP-specific shRNAs or scramble. All values are reported as mean ± SD of three replicates. *p < 0.05, ***p < 0.001, ns = non significance. C, D EdU assays were used to determine the cell proliferation ability of shSPOP transfected HeLa cells. Scar bar: 100 μm. All data shown are mean values ± SD from three replicates. ns = non significance. E Comet assays were used to assess the extent of DNA damage in shSPOP or shp62-transfected HeLa cells, with or without radiation treatment. Scar bar: 10 μm. All data are presented as mean ± SD from three independent replicates. *p < 0.05, ***p < 0.001, ****p < 0.0001, ns = not significant. F, G Colony formation assay of HeLa cells infected with lentivirus expressing SPOP-specific shRNAs in combination with p62/SQSTM1-specific shRNAs. All values are reported as mean ± SD of three replicates. *p < 0.05, **p < 0.01, ns = non significance. H, I Colony formation assay of HeLa cells infected with lentivirus expressing Flag-SPOP in combination with Flag-p62/SQSTM1. All values are reported as mean ± SD from three replicates. *p < 0.05, ****p < 0.0001, ns = non significance. Abbreviations: IR irradiation. SPOP regulates the radiation sensitivity of cervical cancer through p62/SQSTM1 in a DNA damage repair-dependent, proliferation-independent manner. A, B Colony formation assay of SiHa cells infected with lentivirus expressing SPOP-specific shRNAs or scramble. All values are reported as mean ± SD of three replicates. *p < 0.05, ***p < 0.001, ns = non significance. C, D EdU assays were used to determine the cell proliferation ability of shSPOP transfected HeLa cells. Scar bar: 100 μm. All data shown are mean values ± SD from three replicates. ns = non significance. E Comet assays were used to assess the extent of DNA damage in shSPOP or shp62-transfected HeLa cells, with or without radiation treatment. Scar bar: 10 μm. All data are presented as mean ± SD from three independent replicates. *p < 0.05, ***p < 0.001, ****p < 0.0001, ns = not significant. F, G Colony formation assay of HeLa cells infected with lentivirus expressing SPOP-specific shRNAs in combination with p62/SQSTM1-specific shRNAs. All values are reported as mean ± SD of three replicates. *p < 0.05, **p < 0.01, ns = non significance. H, I Colony formation assay of HeLa cells infected with lentivirus expressing Flag-SPOP in combination with Flag-p62/SQSTM1. All values are reported as mean ± SD from three replicates. *p < 0.05, ****p < 0.0001, ns = non significance. Abbreviations: IR irradiation. Furthermore, overexpressed SPOP enhanced the relative cell survival rate after IR (Fig. S8A, B). Moreover, knockdown of p62/SQSTM1 significantly inhibited HeLa cell proliferation, thereby preventing a reduction in their radiosensitivity (Fig. S8C–F). In contrast, overexpression of p62/SQSTM1 notably enhanced the cellular response to radiation, consistent with findings from a previous study [20] (Fig. S8G, H). The potential role of SPOP in modulating the radiation response through the regulation of p62/SQSTM1 was assessed via rescue experiments. SPOP knockdown significantly enhanced the cellular response to radiation, an effect that could not be rescued by p62/SQSTM1 knockdown due to its strong inhibitory impact on proliferation (Fig. 6F, G). However, overexpression of p62/SQSTM1 partially restored the reduced radiation sensitivity of CC cells caused by SPOP overexpression (Fig. 6H, I). Cancer-associated p62/SQSTM1 mutants decrease the effect of SPOP on the radiation sensitivity of tumors Given that SPOP binds to p62/SQSTM1 via the SBC motif, this research investigated patients-derived p62/SQSTM1 mutants in the SBC motif using cancer sequencing data deposited in the cBioPortal database (www.cbioportal.org/). Consistent with previous studies, no SBC motif-localized missense p62/SQSTM1 mutants were observed in CC specimens. However, two mutants (S276Y and S277I) in pancreatic cancer specimens and an S77G mutant in lung cancer specimens were identified (Fig. S9A). Since the p62/SQSTM1 mutant’s amino acid sequence was located near the nuclear localization signal, the subcellular distribution of full-length p62/SQSTM1 WT or mutant (S276Y/S277G/S277I) constructs was observed. It was found that p62/SQSTM1 mutations did not affect the nucleocytoplasmic shuttling of p62/SQSTM1, irrespective of DSBs (Fig. S9B–D). Based on a previous study, the subcellular distribution of full-length p62/SQSTM1-WT or -mutant (S276Y/S277G/S277I) constructs also contained K7A/D69A mutations in the PB1 domain to prevent the interaction of overexpressed constructs with endogenous p62/SQSTM1. Moreover, these p62/SQSTM1 mutations did not affect the nuclear import of the full-length protein, independent of IR used (Fig. S9E, F). Furthermore, how SPOP regulated the expression of p62/SQSTM1 mutants and whether p62/SQSTM1 mutants decreased the effect of SPOP on the radiation sensitivity of tumors was also elucidated. Considering that SPOP modulates p62/SQSTM1-WT levels, how it affects the mutated p62/SQSTM1 protein levels was evaluated by immunoprecipitation (IP) assay. GFP-p62/SQSTM1 plasmids were transiently transfected into the HEK-293T cells. The IP assays revealed that both WT and mutated GFP-p62/SQSTM1 were capable of IP endogenous SPOP. However, the interactions between mutated p62/SQSTM1 (S276Y/S277G/S277I) with SPOP were decreased compared to that between p62/SQSTM1-WT with SPOP (Fig. 7A). Furthermore, p62/SQSTM1 expression increased with co-transfection of Flag-SPOP and mutated p62/SQSTM1 protein than that of Flag-SPOP and WT-p62/SQSTM1 protein. This suggested that SPOP effectively regulated p62/SQSTM1 expression via the SBC motif in Etop -induced DSBs (Fig. 7B). Moreover, it was also found that nuclear but not cytoplasmic p62/SQSTM1 protein was decreased in cells co-transfected with the Flag-p62/SQSTM1-WT and Flag-SPOP plasmids, but total and cytoplasmic as well as nuclear p62/SQSTM1 protein indicated minimal decrease in cells co-transfected with the Flag-p62/SQSTM1-mutants and Flag-SPOP plasmids (Fig. 7B).Fig. 7Patient-derived and SBC motif p62/SQSTM1 mutants decrease the effect of SPOP on the radiation sensitivity of tumors.A Western blot analysis of WCL and Co-IP samples using anti-GFP antibody from HEK-293T cells transfected with the indicated plasmids. B Western blot analysis of the indicated proteins in cytoplasmic fractions and chromatin, as well as HeLa WCL, after 2 h of Etop exposure. C Western blot analysis of HeLa WCL stably expressing EV, p62/SQSTM1-WT, or p62/SQSTM1 mutants, following 2 h of Etop exposure. D Western blot analysis of WCL from HeLa cells with lentivirus-expressing p62/SQSTM1-specific shRNAs, as well as p62/SQSTM1-WT and mutants, after 2 h of Etop exposure. E, F Representative immunofluorescence micrographs showing nuclear RAD51 and γ-H2AX foci in HeLa cells transfected with the indicated plasmids, following 2 h of Etop exposure. Scale bar = 10 μm. Images are enlarged views of selected fields. G HR efficiency in DR-GFP U2OS cells, quantified as the percentage of GFP-positive cells after I-Sce I–induced chromosomal DSBs, following 2 h Etop exposure. **p < 0.01, ***p < 0.001, ****p < 0.0001, ns = not significant, Student’s t-test. H Comet assays to assess the extent of DNA damage in HeLa cells transfected with the indicated plasmids, with or without radiation treatment. Scar bar: 10 μm. All data are presented as mean ± SD from three independent replicates. *p < 0.05, **p < 0.01, ****p < 0.0001, ns = not significant. Abbreviations: Chr chromosome; Cyto cytoplasm, Etop Etoposide, EV empty vector, WCL whole cell lysate. Patient-derived and SBC motif p62/SQSTM1 mutants decrease the effect of SPOP on the radiation sensitivity of tumors. A Western blot analysis of WCL and Co-IP samples using anti-GFP antibody from HEK-293T cells transfected with the indicated plasmids. B Western blot analysis of the indicated proteins in cytoplasmic fractions and chromatin, as well as HeLa WCL, after 2 h of Etop exposure. C Western blot analysis of HeLa WCL stably expressing EV, p62/SQSTM1-WT, or p62/SQSTM1 mutants, following 2 h of Etop exposure. D Western blot analysis of WCL from HeLa cells with lentivirus-expressing p62/SQSTM1-specific shRNAs, as well as p62/SQSTM1-WT and mutants, after 2 h of Etop exposure. E, F Representative immunofluorescence micrographs showing nuclear RAD51 and γ-H2AX foci in HeLa cells transfected with the indicated plasmids, following 2 h of Etop exposure. Scale bar = 10 μm. Images are enlarged views of selected fields. G HR efficiency in DR-GFP U2OS cells, quantified as the percentage of GFP-positive cells after I-Sce I–induced chromosomal DSBs, following 2 h Etop exposure. **p < 0.01, ***p < 0.001, ****p < 0.0001, ns = not significant, Student’s t-test. H Comet assays to assess the extent of DNA damage in HeLa cells transfected with the indicated plasmids, with or without radiation treatment. Scar bar: 10 μm. All data are presented as mean ± SD from three independent replicates. *p < 0.05, **p < 0.01, ****p < 0.0001, ns = not significant. Abbreviations: Chr chromosome; Cyto cytoplasm, Etop Etoposide, EV empty vector, WCL whole cell lysate. Since SPOP can regulate FLNA and RAD51 protein levels by mediating p62/SQSTM1 degradation, it was assessed if p62/SQSTM1 mutants also regulated these proteins. The results indicated that p62/SQSTM1 mutants decreased the protein levels of FLNA and RAD51 compared to the p62/SQSTM1-WT (Fig. 7C, D). Consistently, immunofluorescence also revealed that the nuclear RAD51 and γ-H2AX foci number was also markedly reduced in mutated p62/SQSTM1 overexpressing cells (Figs. 7E, F and S9G, H). Furthermore, p62/SQSTM1 mutants decreased the frequency of HR in cells, especially p62/SQSTM1-S277I overexpressing in cells (Fig. 7G). Notably, comet assays demonstrated that DNA damage was reduced following p62 knockdown, whereas repletion of p62-WT resulted in an increase in DNA damage. Notably, repletion of p62 mutants led to a significantly greater increase in DNA damage compared to p62-WT, with this effect being particularly pronounced after irradiation (Fig. 7H). Considering that the amino acids at mutation sites of p62/SQSTM1 were both serine, it was assessed whether these sites were phosphorylated using the data deposited in the phosphositePlus database (www.phosphosite.org/proteinAction.action?id=4472&showAllSites=true). Phosphorylation was observed in these two sites. Next, whether the binding affinity between p62/SQSTM1 and SPOP alters with S276 or S277 phosphorylation was evaluated (Fig. S10A, B). Co-IP assay results showed that the phosphorylation of p62/SQSTM1 did not affect the SPOP-p62/SQSTM1 interaction (Fig. S10C, D). Furthermore, it was also validated that the p62/SQSTM1 phosphorylation did not affect SPOP-mediated p62/SQSTM1 regulation (Fig. S10E, F). Additionally, the effects of p62/SQSTM1 phosphorylation on the regulation of FLNA and RAD51 were consistent with that of p62/SQSTM1 mutants (Fig. S10G, H). p62/SQSTM1 mutants increase the radiation sensitivity of tumors in vivo and in vitro The functional impact of p62/SQSTM1 on the radiation sensitivity of CC was assessed in vitro by establishing p62/SQSTM1 mutant-overexpressing HeLa cells (Fig. 8A). After IR treatment, p62/SQSTM1 (S276Y/S277G/S277I)-expressing cells showed less growth relative to p62/SQSTM1-WT cells in clone formation and EdU assays, indicating increased sensitivity to IR in vitro (Figs. 8B, C and S11A, B).Fig. 8p62/SQSTM1 mutants increase the radiation sensitivity of tumors in vivo and in vitro.A Western blot analysis of HeLa WCL stably expressing empty vector, p62/SQSTM1-WT, or p62/SQSTM1 mutants. B and C Colony formation assay of HeLa cells infected with lentivirus expressing p62/SQSTM1 mutants or p62/SQSTM1-WT. All values are reported as mean ± SD from three independent replicates. **p < 0.01, ***p < 0.001, ns = not significant. D–F HeLa cells stably expressing p62/SQSTM1-WT or empty control vector were inoculated into NSG nude mice. Tumor length and width were assessed every 2 days. Average tumor size (D), tumor volume (mean ± SD; n = 5 per group) (E), and tumor weight on day 35 after inoculation (F). *p < 0.05. Scar bar: 2 cm. G–I HeLa cells stably expressing p62/SQSTM1-WT or empty control vector were inoculated into NSG nude mice and tumors irradiated with 2 Gy on day 45. Tumor length and width were assessed every 2 days. Average tumor size (G), tumor volume (mean ± SD; n = 5/group) (H), and tumor weight on day 60 after inoculation (I). *p < 0.05, ns = not significant. Scale bar = 2 cm. J–L HeLa cells stably expressing p62/SQSTM1-WT, p62/SQSTM1-S227G, or p62/SQSTM1-S277I were inoculated into NSG nude mice. Tumor length and width were assessed every 2 days. Average tumor size (J), tumor volume (mean ± SD; n = 5/group) (K), and tumor weight on day 18 after inoculation (L). ns = not significant. Scale bar = 2 cm. M–O HeLa cells stably expressing p62/SQSTM1-WT, p62/SQSTM1-S227G, or p62/SQSTM1-S277I were inoculated into NSG nude mice and tumors irradiated with 2 Gy on day 13. Tumor length and width were assessed every 2 days. Average tumor size (M), tumor volume (mean ± SD; n = 5/group) (N), and tumor weight on day 20 after inoculation (O). **p < 0.01, ***p < 0.001, ****p < 0.0001, ns = not significant. Scale bar = 2 cm. Abbreviations: IR irradiation, WCL whole-cell lysates. p62/SQSTM1 mutants increase the radiation sensitivity of tumors in vivo and in vitro. A Western blot analysis of HeLa WCL stably expressing empty vector, p62/SQSTM1-WT, or p62/SQSTM1 mutants. B and C Colony formation assay of HeLa cells infected with lentivirus expressing p62/SQSTM1 mutants or p62/SQSTM1-WT. All values are reported as mean ± SD from three independent replicates. **p < 0.01, ***p < 0.001, ns = not significant. D–F HeLa cells stably expressing p62/SQSTM1-WT or empty control vector were inoculated into NSG nude mice. Tumor length and width were assessed every 2 days. Average tumor size (D), tumor volume (mean ± SD; n = 5 per group) (E), and tumor weight on day 35 after inoculation (F). *p < 0.05. Scar bar: 2 cm. G–I HeLa cells stably expressing p62/SQSTM1-WT or empty control vector were inoculated into NSG nude mice and tumors irradiated with 2 Gy on day 45. Tumor length and width were assessed every 2 days. Average tumor size (G), tumor volume (mean ± SD; n = 5/group) (H), and tumor weight on day 60 after inoculation (I). *p < 0.05, ns = not significant. Scale bar = 2 cm. J–L HeLa cells stably expressing p62/SQSTM1-WT, p62/SQSTM1-S227G, or p62/SQSTM1-S277I were inoculated into NSG nude mice. Tumor length and width were assessed every 2 days. Average tumor size (J), tumor volume (mean ± SD; n = 5/group) (K), and tumor weight on day 18 after inoculation (L). ns = not significant. Scale bar = 2 cm. M–O HeLa cells stably expressing p62/SQSTM1-WT, p62/SQSTM1-S227G, or p62/SQSTM1-S277I were inoculated into NSG nude mice and tumors irradiated with 2 Gy on day 13. Tumor length and width were assessed every 2 days. Average tumor size (M), tumor volume (mean ± SD; n = 5/group) (N), and tumor weight on day 20 after inoculation (O). **p < 0.01, ***p < 0.001, ****p < 0.0001, ns = not significant. Scale bar = 2 cm. Abbreviations: IR irradiation, WCL whole-cell lysates. Moreover, to verify the effects of p62/SQSTM1-WT mutants in vivo, stable p62/SQSTM1-WT and mutations overexpressing HeLa cells were subcutaneously injected into immunodeficient mice. The pattern diagram is shown in Fig. S11C. First, p62/SQSTM1-WT overexpressing HeLa cells were injected (Fig. S11D), which revealed that mice had increased tumor volume compared to mice injected with HeLa cells with an empty plasmid (Figs. 8D–F and S11E). The body weight was not substantially different between various groups (Fig. S11F). Moreover, the p62/SQSTM1 overexpressing HeLa tumor tissues indicated markedly increased expression of p62/SQSTM1 and Ki67 (Fig. S11G, H). Next, whether p62/SQSTM1 expression affects the growth of cancer cells after IR treatment was investigated. The data revealed that after IR, p62/SQSTM1 over-expressing tumors showed the same growth relative to empty plasmid tumors, indicating increased sensitivity to IR (Figs. 8G–I and S11I, J). In addition, a slight reduction was observed in body weight after IR; however, it was not significantly different between various groups (Fig. S11K). The expressions of FLNA and RAD51 after IR in p62/SQSTM1-overexpressing tumor tissues were significantly decreased (Fig. S11L, M). To investigate if p62/SQSTM1 mutants reduced tumor growth ex vivo, p62/SQSTM1 plasmids, including p62/SQSTM1-WT, p62/SQSTM1 (S277G), and p62/SQSTM1 (S277I), were transfected into the HeLa cells, which were then subcutaneously injected into immunodeficient mice for tumors formation (Figure S12A). It was observed that the tumor volume in p62/SQSTM1-WT HeLa cells injected mice was similar to that of p62/SQSTM1 (S277G/S277I)-expressing group (Figs. 8J–L and S12B). However, the body weight was not substantially different among various groups (Fig. S12C). The expression of p62/SQSTM1 and Ki-67 also had a similar trend (Fig. S12D, E). However, IR treatment resulted in reduced tumor growth in the p62/SQSTM1 (S277G/S277I) group relative to the p62/SQSTM1-WT group, indicating increased sensitivity to IR (Figs. 8M–O and S12F, G). In addition, the body weight showed a similar trend after IR (Fig. S12H). Furthermore, the FLNA and RAD51 expressions in the p62/SQSTM1(S277G/S277I) group were also decreased after IR (Fig. S12I, J). Of note, we assessed the expression of SPOP and p62 in cervical cancer cells through immunohistochemical (IHC) staining of clinical samples from a tissue microarray. Compared to normal tissue, we observed that SPOP was highly expressed in the nucleus of cervical cancer cells, while p62 expression was notably reduced in the nucleus (Fig. 9A–F). In contrast, both SPOP and p62 were highly expressed in the cytoplasm (Fig. S13A–D).Fig. 9Expression of SPOP and p62 in cervical cancer clinical samples and schematic diagram.Immunohistochemical staining analysis of SPOP (A) and p62 (B) expression in cervical cancer tumor cells. C–F Comparison of SPOP and p62 expression in paired tumor and adjacent normal tissue samples, with a focus on nuclear localization. C SPOP staining: n = 120 (105 tumor samples, 15 normal samples). E p62 staining: n = 120 (105 tumor samples, 15 normal samples). G Schematic diagram depicting the association of both SPOP and p62/SQSTM1 with the radiotherapy sensitivity of cervical cancer. Expression of SPOP and p62 in cervical cancer clinical samples and schematic diagram. Immunohistochemical staining analysis of SPOP (A) and p62 (B) expression in cervical cancer tumor cells. C–F Comparison of SPOP and p62 expression in paired tumor and adjacent normal tissue samples, with a focus on nuclear localization. C SPOP staining: n = 120 (105 tumor samples, 15 normal samples). E p62 staining: n = 120 (105 tumor samples, 15 normal samples). G Schematic diagram depicting the association of both SPOP and p62/SQSTM1 with the radiotherapy sensitivity of cervical cancer. Discussion This research demonstrates that, in the context of DNA damage, nuclear SPOP interacts with and ubiquitinates nuclear p62, leading to its degradation. Moreover, the expression levels of SPOP and p62/SQSTM1 genes significantly influence the sensitivity of CC to radiotherapy by inhibiting the levels of FLNA and RAD51 proteins, reducing the formation of RAD51 nuclear foci in conjunction with γ-H2AX, and impairing HR repair efficiency. Notably, cancer-associated p62/SQSTM1 mutants were found to diminish the impact of SPOP on tumor radiation sensitivity, while paradoxically increasing radiation sensitivity in both in vivo and in vitro settings. The research also found that DNA DSBs enhanced the interaction between SPOP and p62/SQSTM1, particularly in the nucleus. However, Shi et al. observed that cytoplasmic SPOP, but not nuclear SPOP, exclusively colocalized with p62/SQSTM1 following co-expression of both proteins [22]. This discrepancy may be explained by our recent observation that IR enhances nuclear import of p62/SQSTM1 [31], thereby increasing the SPOP–p62/SQSTM1 interaction within the nucleus. Moreover, it was found that SPOP binds to and ubiquitinates nuclear p62 at residue K7, targeting it for degradation. In 2016, Pan et al. demonstrated that TRIM21 directly interacts with SQSTM1/p62 and ubiquitinates p62 at lysine 7 (K7), playing a crucial role in redox regulation [32]. Recently, Zhu et al. reported that TRIM21 inhibits CHK1 activation, compromising replication fork stability and promoting tumorigenesis [33]. Therefore, whether TRIM21-mediated p62 ubiquitination regulates the DDR and how it compares to SPOP-mediated p62 ubiquitination remains to be fully elucidated. To further characterize the K7 site, we performed mass spectrometry (MS) analysis. We attempted to map the precise ubiquitination sites on nuclear p62/SQSTM1 by mass spectrometry following DNA damage. However, despite two independent MS analyses of nuclear fractions (and two of cytoplasmic fractions), we did not detect ubiquitination at K7 or at the previously reported K420 site [22], and the MS data showed variability between replicates (Supplementary Material 3–6). We attribute these limitations to the typically low stoichiometry and rapid turnover of ubiquitination, particularly at these lysine residues, as well as potential inefficiency of trypsin digestion. Of note, the previously reported TRIM21-mediated ubiquitination of p62 at K7 was also validated solely by mutagenesis and ubiquitination assays, without mass spectrometry evidence [32]. Similarly, the K420 site originally reported by Shi et al. was identified based on mutagenesis and in vivo ubiquitination assays, also without MS validation [22]. This indicates that the inability to detect K7 by MS is not unprecedented and does not invalidate the functional conclusion. Importantly, the lack of MS detection does not undermine the functional evidence: our in vivo and in vitro ubiquitination assays using point mutants consistently and reproducibly demonstrated that K7 is required for nuclear ubiquitination and K420 for cytoplasmic ubiquitination. We therefore conclude that K7 is a functionally validated nuclear ubiquitination site, while acknowledging the technical constraints of MS in detecting these specific modifications. This study also revealed that SPOP enhances the protein levels of RAD51 and FLNA by promoting the degradation of nuclear p62/SQSTM1, both of which are key factors directly involved in HR repair. Notably, this is the first report demonstrating that SPOP knockdown reduces FLNA protein levels. Previous studies have shown that SPOP can regulate RAD51 expression at the transcriptional level [34]. Dong et al. found that the knockdown of SPOP increased the RAD51 protein levels [21]. Therefore, the RAD51 expression might be regulated at multiple levels based on the different conditions and the protein levels. Here, the observed effect of p62/SQSTM1 on RAD51 and FLNA was consistent with previous reports [19, 35]. In addition, SPOP has been observed to promote RAD51 foci formation for γ-H2AX, which was consistent with the results of El Bezawy [30]. Moreover, p62/SQSTM1 has been reported to inhibit HR repair of DSBs [12, 19, 20]; however, this is the first research to report that SPOP can regulate RAD51 and FLNA, key HR repair factors, by degrading nuclear p62/SQSTM1. At a functional level, phenocopy experiments showed that SPOP and p62/SQSTM1 can regulate the radiation sensitivity of tumor cells. Here, for the first time, it was indicated that SPOP knockdown can increase the radiation sensitivity of CC cells, which was consistent with the results observed in other cancers [21, 30]. Furthermore, this research also revealed that p62/SQSTM1 overexpression enhances CC cell response to radiation, similar to what was observed by Wang et al. [20]. Here, SPOP was observed to respond to radiation by influencing the expression of p62/SQSTM1 and DDR. Overall, it was validated that SPOP downregulation improved the radiation response of CC models by upregulating nuclear p62/SQSTM1 protein levels, which reduces the expression of RAD51 and FLNA protein (the DNA repair factors), impairs RAD51 and γ-H2AX foci formation, and impedes HR repair efficiency. Shi et al. analyzed the sequencing data from the BioPortal database (www.cbioportal.org/) and demonstrated that there were three SBC motif-localized missense p62/SQSTM1 mutations, including S276Y and S277I in pancreatic cancer and an S277G mutation in lung cancer specimens [22]. However, the function of these p62/SQSTM1 mutants remains unknown. Here, it was observed that the p62/SQSTM1 mutants decreased the effect of SPOP on the radiation sensitivity of tumors and increased the radiation sensitivity of tumors in vivo and in vitro. Furthermore, the SPOP-binding ability of these p62/SQSTM1 mutants was not completely abolished, but impaired as compared to p62/SQSTM1-WT, which was inconsistent with the co-IP analysis of SPOP and p62/SQSTM1 mutants reported by Shi et al. [22]. However, they also indicated that SPOP-mediated ubiquitination of p62/SQSTM1 mutants was attenuated, but not completely abolished [22]. This may explain the interaction between SPOP and p62/SQSTM1 mutants. This research also elucidated the precise mechanisms by which p62/SQSTM1 mutants decreased the effect of SPOP on cellular radiation resistance in CC. The data revealed that reduced SPOP-mediated degradation increased expression of these mutants, thereby causing the degradation of FLNA and RAD51 proteins, decreased number of RAD51 and γ-H2AX foci formation, and impaired HR repair efficiency. There were only two reports on the function of p62/SQSTM1 mutants located in other sites. Deng et al. indicated that p62/SQSTM1-G427R mutation impairs KEAP1-p62/SQSTM1 interaction, which disrupts anti-oxidative stress response. Furthermore, pathogenic p62/SQSTM1-G427R also inhibits selective autophagy [36]. Battista et al. found that mutant p62/SQSTM1 lacking the ubiquitin- and LC3-binding domains, required for autophagic engulfment, can increase epithelial cancer chemoresistance [37]. Here, it was reported that p62/SQSTM1 mutants in the SBC motif can reduce the effect of SPOP on radiation sensitivity and decrease cancer radiation resistance. Moreover, it was found that point mutations, p62/SQSTM1-S276Y, p62/SQSTM1-S277G, and p62/SQSTM1-S277I, do not affect the nuclear import of the full-length protein, which was consistent with the study of Hewitt [19]. However, the underlying mechanisms warrant further research. This investigation suggested that phosphorylation of p62/SQSTM1 at serine 276 and 277 cannot affect the SPOP-p62/SQSTM1 interaction, which was not consistent with the study of Zhuang et al. who reported that SBC phosphorylation in MacroH2A and Puc blocks the binding to SPOP [8]. Further studies on the SBC phosphorylation of other substrates at different sites and the responding biochemical functions are required. Ichimura et al. accessed the physiological importance of phosphorylation of p62/SQSTM1 in cancer and found that the phosphorylation of p62/SQSTM1 at 351 and 352 sites can activate the Keap1-Nrf2 pathway during selective autophagy [38]. Ikeda et al. also showed that Ser349-phosphorylated p62/SQSTM1 participates in the redox-independent activation of NRF2 [39]. Moreover, Linares et al. revealed that phosphorylates p62/SQSTM1 at T269 and S272 and modulates cell proliferation and tumorigenesis in response to Ras-induced transformation [40]. Matsumoto et al. found that phosphorylation at serine 403 of p62/SQSTM1 regulated selective autophagic clearance of ubiquitinated proteins [41]. Therefore, the exact role of p62/SQSTM1 phosphorylation at different sites requires comprehensive analyses. Overall, this research found that in the case of DNA DSBs, the interaction between SPOP and p62/SQSTM1 was significantly intensified and predominantly in the nucleus. Furthermore, SPOP can promote the degradation of p62/SQSTM1 in the nucleus, thereby upregulating the RAD51 and FLNA protein levels, which are the key factors involved in HR repair, thus promoting RAD51 foci formation for γ-H2AX and HR repair efficiency. At a functional level, SPOP reduces the radiotherapy sensitivity of CC cells by promoting the degradation of nuclear p62/SQSTM1. Moreover, p62/SQSTM1 mutants reduced SPOP’s effect on the tumor’s radiation sensitivity and enhanced this sensitivity in vivo and in vitro by enhancing the degradation of RAD51 and FLNA, inhibiting RAD51 foci formation for γ-H2AX, and impairing HR repair efficiency. In summary, this research revealed that SPOP inhibits the radiotherapy sensitivity of CC by enhancing HR repair efficiency. Furthermore, p62/SQSTM1 mutants increased the sensitivity of CC to radiotherapy by impeding HR repair efficiency (Fig. 9G). This investigation provided important clinical evidence and a basis for exploring potential targets for radiotherapy sensitization of CC. Supplementary information Supplementary Figures 1-13 Supplementary Tables 1-2 Supplementary material 1 Supplementary material 2 Supplementary Material 3 Supplementary Material 4 Supplementary Material 5 Supplementary Material 6 Supplementary Figures 1-13 Supplementary Tables 1-2 Supplementary material 1 Supplementary material 2 Supplementary Material 3 Supplementary Material 4 Supplementary Material 5 Supplementary Material 6